Publications
Download CSV
Download XLSX
Download TXT
Tables
2024 (428)
2023 (585)
2022 (723)
2021 (1399)
2020 (842)
All (3977)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Nilsson P
JSON
CSV
XLSX
TXT
Family name
Nilsson
Given name
Peter
Initials
P
ORCID
ORCID
0000-0002-4657-8532
Affiliations
Division of Affinity Proteomics Department of Protein Science KTH Royal Institute of Technology SciLifeLab Stockholm Sweden.
11 publications
DOI
Crossref
Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers
Marking U, Havervall S, Norin NG, ...,
Klingström J
,
Thålin C
Nat Commun
14
(1) - [2023-03-22; online 2023-03-22]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Research Area: Biobanks for COVID-19 research
Type: Journal article
PubMed
DOI
Crossref
Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination.
Blixt L,
Gao Y
,
Wullimann D
, ...,
Hansson L
, Österborg A
Blood
140
(22) 2403-2407 [2022-12-01; online 2022-09-24]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Type: Journal article
PubMed
DOI
Crossref
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines.
Marking U,
Havervall S
, Greilert-Norin N, ..., Åberg M, Thålin C
Vaccines
10
(3) 359 [2022-02-24; online 2022-02-24]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: Biobanks for COVID-19 research
Research Area: Drug discovery and repurposing of drugs
Research Area: High-throughput and high-content serology
Type: Journal article
PubMed
DOI
Crossref
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
Havervall S
,
Jernbom Falk A
,
Klingström J
, ...,
Nilsson P
, Thålin C
PLoS One
17
(1) e0262169 [2022-01-12; online 2022-01-12]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: Biobanks for COVID-19 research
Research Area: Drug discovery and repurposing of drugs
Research Area: High-throughput and high-content serology
Research Area: Host cell systems biology and targets
Type: Journal article
PubMed
DOI
Crossref
Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals
Healy K,
Pin E
, Chen P, ...,
Aleman S
, Sällberg Chen M
Med (N Y)
-
(-) - [2022-01-00; online 2022-01-00]
Category: Biochemistry
Category: Health
Category: Vaccines
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: Vaccine
Type: Journal article
DOI
Crossref
Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time
Havervall S
, Marking U, Greilert‐Norin N, ..., Åberg M, Thålin C
Clin Transl Immunol
11
(4) - [2022-01-00; online 2022-04-18]
Category: Biochemistry
Category: Health
Category: Vaccines
Funder: KAW/SciLifeLab National COVID program
Research Area: Biobanks for COVID-19 research
Research Area: High-throughput and high-content serology
Type: Journal article
PubMed
DOI
Crossref
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall S
,
Ng H
,
Jernbom Falk A
, ...,
Hober S
,
Thålin C
J Intern Med
291
(1) 72-80 [2022-01-00; online 2021-09-27]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Research Area: Biobanks for COVID-19 research
Research Area: Drug discovery and repurposing of drugs
Research Area: High-throughput and high-content serology
Research Area: Host cell systems biology and targets
Research Area: Viral sequence evolution
PubMed
DOI
Crossref
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients.
Blixt L, Bogdanovic G, Buggert M, ...,
Hansson L
,
Österborg A
Leukemia
-
(-) - [2021-09-25; online 2021-09-25]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: High-throughput and high-content serology
Type: Journal article
PubMed
DOI
Crossref
Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis
Asplund Högelin K,
Ruffin N
, Pin E, ..., Piehl F, Al Nimer F
iScience
24
(9) 103078 [2021-09-00; online 2021-09-00]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Research Area: High-throughput and high-content serology
Research Area: Vaccine
Type: Journal article
PubMed
DOI
Crossref
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.
Hober S
, Hellström C,
Olofsson J
, ...,
Hedhammar M
,
Nilsson P
Clin Transl Immunol
10
(7) e1312 [2021-07-19; online 2021-07-19]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Research Area: Biobanks for COVID-19 research
Research Area: High-throughput and high-content serology
Research Area: Host cell systems biology and targets
Type: Journal article
PubMed
DOI
Crossref
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.
Rudberg AS
, Havervall S,
Månberg A
, ...,
Hober S
,
Thålin C
Nat Commun
11
(1) 5064 [2020-10-08; online 2020-10-08]
Category: Health
Category: Serology
Funder: H2020
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: Biobanks for COVID-19 research
Research Area: High-throughput and high-content serology
Research Area: Host cell systems biology and targets
Type: Journal article
SciLifeLab Data Centre
Publications
9.5.1